Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
05/2012
05/24/2012WO2012068537A2 New biocatalysts and primers for production of chemicals
05/24/2012WO2012068519A2 Markers associated with response to activated protein c administration, and uses thereof
05/24/2012WO2012068511A2 Method for amplification-free nucleic acid detection on optofluidic chips
05/24/2012WO2012068468A1 Method of treatment with braf inhibitor
05/24/2012WO2012068446A1 Viability cell counting by differential light absorption
05/24/2012WO2012068400A2 Mirnas as biomarkers for distinguishing benign from malignant thyroid neoplasms
05/24/2012WO2012068392A2 Low cost, portable sensor for molecular assays
05/24/2012WO2012068383A2 ncRNA AND USES THEREOF
05/24/2012WO2012068339A2 Methods of treating cancer
05/24/2012WO2012068288A2 Diagnosing and monitoring cns malignancies using microrna
05/24/2012WO2012068287A2 System for identifying and sorting living cells
05/24/2012WO2012068245A1 Methods for identifying subjects at risk of developing psychiatric disorders during interferon-alpha treatment
05/24/2012WO2012068232A1 Aurora a kinase effectors
05/24/2012WO2012068170A2 Generation of neural stem cells from human trophoblast stem cells
05/24/2012WO2012068107A2 Autoantibody to rna-protein complex detected by quantitative pcr
05/24/2012WO2012068003A2 Particle focusing systems and methods
05/24/2012WO2012067970A2 Transcriptional repression leading to parkinson's disease
05/24/2012WO2012067925A1 Genetic loci associated with resistance of corn to fijivirus
05/24/2012WO2012067911A1 Methods for sequencing a biomolecule by detecting relative positions of hybridized probes
05/24/2012WO2012067901A1 Methods and kits for multiplex amplification of short tandem repeat loci
05/24/2012WO2012067831A1 Real time cleavage assay
05/24/2012WO2012067830A2 Methylation assay
05/24/2012WO2012067828A1 Mutation detection assay
05/24/2012WO2012067525A1 Genotypes and selenium level as a markers of breast/ovarian cancer risk in brca1 mutation carriers
05/24/2012WO2012067465A2 Automatic necleic acid purification apparatus and method for aerosol-protecting
05/24/2012WO2012067460A2 Method for screening for materials for promoting the differentiation of skin cells
05/24/2012WO2012067450A2 Efemp1 gene as a diagnostic marker for prostate cancer
05/24/2012WO2012067288A1 Preparation method of aptamer
05/24/2012WO2012067259A1 Method for detecting low concentrations of specific cell from high concentrations of contaminating cell populations, and method for collecting and analyzing detected cell
05/24/2012WO2012066582A1 Genetic risk factors of sick sinus syndrome
05/24/2012WO2012066576A2 Oligonucleotide primer sequences for detection of leptospira
05/24/2012WO2012066536A2 Transcriptome signatures discriminate etanercept-treated rheumatoid arthritis (ra) patients according to their response or refractory status
05/24/2012WO2012066500A1 Flow-through apparatus
05/24/2012WO2012066499A1 Flow-through apparatus
05/24/2012WO2012066451A1 Prognostic and predictive gene signature for colon cancer
05/24/2012WO2012066321A1 Biosensor and uses thereof
05/24/2012WO2012066161A1 Glutamyl aminopeptidase as a marker of renal damage
05/24/2012WO2012066141A1 Markers for acute kidney injury and uses thereof
05/24/2012WO2012066121A1 Method for detecting nucleic acids
05/24/2012WO2012065705A1 Novel complex mutation in the epidermal growth factor receptor kinase domain
05/24/2012WO2012065480A1 Nanopore sensor of sub-nanometer thickness
05/24/2012WO2012065231A1 Signal amplification
05/24/2012WO2012065228A1 Pongamia genetic markers and method of use
05/24/2012WO2012049465A8 Assay device
05/24/2012WO2012046006A3 Cutaneous squamous cell carcinoma target sequences
05/24/2012WO2012042211A3 Glucose electrochemical measurement method with error detection
05/24/2012WO2012040500A3 Direct blood assay for detection of circulating microrna in cancer patients
05/24/2012WO2012038831A3 A method for detecting, quantifying and mapping damage and/or repair of dna strands
05/24/2012WO2012027617A3 Systems and methods for detecting normal levels of bacteria in water using a multiple angle light scattering (mals) instrument
05/24/2012WO2012019000A3 Biomarkers for the identification monitoring and treatment of ovarian cancer
05/24/2012WO2012018613A3 Genetic make-up modifies cancer outcome
05/24/2012WO2012012797A3 Methods for isolating and using a subset of cd8 t-cells that are resistant to cyclosporin
05/24/2012WO2012012704A3 Methods of detecting kidney-associated diseases or conditions
05/24/2012WO2012012510A3 Gene expression profiling for the identification of lung cancer
05/24/2012WO2012011778A3 Cancer diagnosis kit and pharmaceutical composition for prevention or treatment of cancer
05/24/2012WO2012011777A3 Kit for diagnosing colorectal cancer and pharmaceutical composition for prevention or treatment of colorectal cancer
05/24/2012WO2012009547A3 Biomarkers for diagnosis of transient ischemic attacks
05/24/2012WO2012009499A3 Assessing thyroid neoplasms and treating cancer
05/24/2012WO2011156690A3 Methods for the development of vaccines based on oligosaccharide-oligonucleotide conjugates
05/24/2012US20120131692 Brassica gat event dp-073496-4 and compositions and methods for the identification and/or detection thereof
05/24/2012US20120131690 Brassica gat event dp-061061-7 and compositions and methods for the identification and/or detection thereof
05/24/2012US20120130648 Determination of the risk of distant metastases in surgically treated patients with non-small cell lung cancer in stage i-iiia
05/24/2012US20120129957 Analyzing the fmr1 gene
05/24/2012US20120129910 Inhibition of Apoptosis-Specific eIF-5A(elF-5A1") with Antisense Oligonucleotides and siRNA as Anti-Inflammatory Therapeutics
05/24/2012US20120129901 Triterpenoid derivatives useful as antiproliferative agents
05/24/2012US20120129880 Method for determining sensitivity to irinotecan and use thereof
05/24/2012US20120129869 Phosphorylation and mutations of anaplastic lymphoma kinase as a diagnostic and therapeutic target in lung cancer
05/24/2012US20120129856 Compounds, compositions and methods useful for cholesterol mobilisation
05/24/2012US20120129835 Schizophrenia methods and compositions
05/24/2012US20120129805 Barley and uses thereof
05/24/2012US20120129794 Apparati, methods, and compositions for universal microbial diagnosis, detection, quantification, and specimen-targeted therapy
05/24/2012US20120129788 Phosphodiesterase 4d7 as marker for malignant, hormone-sensitive prostate cancer
05/24/2012US20120129782 Inhibition of ApoE Cleavage Activity in the Treatment of ApoE-Related Disorders
05/24/2012US20120129777 Methods for Treating Bleeding Disorders Using Sulfated Polysaccharides
05/24/2012US20120129725 Nucleic acid nano-biosensors
05/24/2012US20120129724 Marker and reagent for detection of human il-17-producing helper t cells, and method for detection of human il-17-producing helper t cells
05/24/2012US20120129714 Quantitative multiplexed identification of nucleic acid targets
05/24/2012US20120129711 Biomarkers for the prognosis and high-grade glioma clinical outcome
05/24/2012US20120129706 Method of Assessing Soil Quality and Health
05/24/2012US20120129705 Diagnostic markers for determining the predisposition to the development of cervical cancer and oligonucleotides used for the determination
05/24/2012US20120129704 Generation of uniform fragments of nucleic acids using patterned substrates
05/24/2012US20120129211 Titration of differentiation medium components
05/24/2012US20120129210 Method for Assaying Inositol Hexaphosphate (IHP)
05/24/2012US20120129209 Aligning cells on wrinkled surface
05/24/2012US20120129208 Honeycomb shrink wells for stem cell culture
05/24/2012US20120129207 Compositions and methods of functionally enhanced in vitro cell culture system
05/24/2012US20120129206 Method of identifying patients suitable for high-dose cyclophosphamide treatment
05/24/2012US20120129205 Novel Nitroreductase Enzymatic Substrates
05/24/2012US20120129204 Novel nitroreductase enzymatic substrates
05/24/2012US20120129203 Novel Peptidase Substrates
05/24/2012US20120129202 Composition for assaying glycated proteins
05/24/2012US20120129201 Mass spectrometry imaging with substance identification
05/24/2012US20120129195 Method of quick laboratory diagnosis if illnesses based on the discovery of specific proteins and equipment for its implementation
05/24/2012US20120129190 Ensemble-decision aliquot ranking
05/24/2012US20120129189 Methods of Controlling Cell Proliferation
05/24/2012US20120129187 Diagnostical use of peroxiredoxin 4
05/24/2012US20120129184 Systemic carnitine deficiency gene and uses thereof
05/24/2012US20120129183 Methods and kits for isolating placental derived microparticles and use of same for diagnosis of fetal disorders
05/24/2012US20120129182 Amplification of complex nucleic acids
05/24/2012US20120129181 Detection of bacterial (mollicutes) contamination